2.76
-0.08(-2.82%)
Currency In USD
| Previous Close | 2.84 |
| Open | 2.8 |
| Day High | 2.84 |
| Day Low | 2.68 |
| 52-Week High | 4.67 |
| 52-Week Low | 0.89 |
| Volume | 2.31M |
| Average Volume | 4.37M |
| Market Cap | 125.77M |
| PE | -4.76 |
| EPS | -0.58 |
| Moving Average 50 Days | 3.37 |
| Moving Average 200 Days | 2.47 |
| Change | -0.08 |
If you invested $1000 in Microbot Medical Inc. (MBOT) 10 years ago, it would be worth $4.26 as of October 17, 2025 at a share price of $2.76. Whereas If you bought $1000 worth of Microbot Medical Inc. (MBOT) shares 5 years ago, it would be worth $354.76 as of October 17, 2025 at a share price of $2.76.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting
GlobeNewswire Inc.
Yesterday at 12:30 PM GMT
First U.S. Based Medical Meeting Presence Post-FDA Clearance Will Allow the Company to Commercially Engage Future Potential Users of the LIBERTY® System Company Completes the Recruitment of its Commercial Leadership Team as it Remains On Track to Co
Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System
GlobeNewswire Inc.
Oct 14, 2025 12:30 PM GMT
The Experienced MedTech Logistics Provider Will Help Ensure Effective and Efficient Inventory Management and Customer Support The Company is on Track to Commence the Launch of LIBERTY® during Q4 This Year HINGHAM, Mass., Oct. 14, 2025 (GLOBE NEWSW
Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
GlobeNewswire Inc.
Oct 07, 2025 12:00 PM GMT
$25.2 million in first closing, $1.2 million in second closing and $2.8 million in third and final closing, with up to an additional approximately $63 million of potential aggregate gross proceeds upon the exercise in full of short-term preferred inv